Remote CBT-Based Therapy Yields Modest Improvements in Chronic Pain
By Elana Gotkine HealthDay Reporter

MONDAY, July 28, 2025 -- Remote-scalable cognitive behavioral therapy (CBT)-based chronic pain (CP) treatments yield modest improvements in high-impact chronic pain compared with usual care, according to a study published online July 23 in the Journal of the American Medical Association.
Lynn L. DeBar, Ph.D., M.P.H., from the Kaiser Permanente Center for Health Research in Portland, Oregon, and colleagues examined the effectiveness of remote, scalable CBT-CP treatments (telehealth and self-completed online) for individuals with high-impact chronic pain. A total of 2,331 eligible patients with high-impact chronic musculoskeletal pain were enrolled and randomly assigned to one of two remote, eight-session CBT-based skills training treatments -- health coach-led telephone/videoconferencing (health coach; 778 participants) or online self-completed program (painTRAINER; 776 participants) -- or usual care plus a resource guide (777 participants).
The researchers found that the adjusted percentages of participants achieving a 30 percent or greater decrease in the pain severity score were 32.0, 26.6, and 20.8 percent in the health coach group, the painTRAINER group, and the usual care group, respectively, at three months. Compared with control, both intervention groups were significantly more likely to attain a minimal clinically important difference in pain severity (relative risks, 1.54 and 1.28 for health coach and painTRAINER, respectively, versus usual care); the health coach program was more effective than the online self-completed painTRAINER program (relative risk, 1.20). At six and 12 months, statistically significant benefits were observed for both intervention groups versus usual care.
"Centralizing delivery of the CBT-CP-based programs via telephone/videoconferencing and online interventions is effective, with potential for widespread dissemination into clinical care and health care organizations nationwide," the authors write.
An institution holds the copyright to painTRAINER on behalf of one of the authors.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-29 06:00
Read more

- Thresholds for Preop Serum Calcitonin Predict Lymph Node Metastasis in Thyroid Cancer
- Vaping Better At Helping Smokers Quit, Clinical Trial Indicates
- Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis
- American Academy of Pediatrics Sues HHS Over Vaccine Policy
- Genentech Provides Update on Astegolimab in Chronic Obstructive Pulmonary Disease
- High Levels of Particulate Matter Found Near Electric Vehicle Charging Stations in L.A.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions